Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer

SIMPLE SUMMARY: Colorectal cancer is the third most common cancer worldwide. The treatment of the advanced stages is based on poly-chemotherapies, including oxaliplatin. However, the development of resistance to chemotherapy is observed in 50% of cases, leading to treatment failures. A better unders...

Descripción completa

Detalles Bibliográficos
Autores principales: Chocry, Mathieu, Leloup, Ludovic, Parat, Fabrice, Messé, Mélissa, Pagano, Alessandra, Kovacic, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740936/
https://www.ncbi.nlm.nih.gov/pubmed/36497380
http://dx.doi.org/10.3390/cancers14235894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740936/
https://www.ncbi.nlm.nih.gov/pubmed/36497380
http://dx.doi.org/10.3390/cancers14235894

Ejemplares similares